TSX:HLS (HLS Therapeutics Inc.)
About HLS
HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company is focused on treatment products for the central nervous system (CNS), and cardiovascular specialties. The company products include Clozaril, Absorica, Vascepa, CSAN Pronto, Trinomia and Perseris. The company earns revenue in the form of product sales and royalties, out of which product sales contribute to the majority of the revenue. The company operates in Canada, the United States and the Rest of the world.
HLS Therapeutics Inc. (TSX: HLS) Latest News
Cannabis Stocks
3 Pot Stocks Robinhood Investors Should Buy Instead of Aurora Cannabis (TSX:ACB)
Cannabis Stocks
3 Pot Stocks That Can Soar After Q3 Earnings
Cannabis Stocks
Why Is This Pot Stock Crushing Canopy Growth (TSX:WEED) in 2020?
Cannabis Stocks
Got $1,000? Here’s the Top Pot Stock to Buy Right Now
Cannabis Stocks
Better Than Canopy Growth (TSX:WEED): This Red-Hot Pot Stock Is Already up 70% in 2020
Cannabis Stocks
TFSA Investors: Is it Time to Bet on This Billion-Dollar Pot Stock?
Cannabis Stocks
2 Reasons Why This Top Cannabis Company Might Be a Buy
❮2